Latest Period
Q1 2026
Security Snapshot
Aspire Biopharma Holdings, Inc. - Common Stock, par value $0.0001 per share (ASBP) Institutional Ownership
CUSIP: 738920107
13F Institutional Holders and Ownership History from Q1 2025 to Q1 2026
Institutions Reporting
2
Shares (Excl. Options)
25,348
Price
$0.67
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- ASBP on Nasdaq
- Shares outstanding
- 5,250,000
- Price per share
- $0.67
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 25,348
- Total reported value
- $8,453
- % of total 13F portfolios
- 0%
- Share change
- -6,117,538
- Value change
- -$841,693
- Number of holders
- 2
- Price from insider filings
- $0.67
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- ASBP - Aspire Biopharma Holdings, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 738920107.
- 2 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 30 to 2 between Q4 2025 and Q1 2026.
- Reported value moved from $899,822 to $8,453.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 2 institutions filings for Q1 2026.
Security key
738920107
Latest holder period
Q1 2026
13F holders
2
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
ASBP full holder history
Aspire Biopharma Holdings, Inc. SEC filings
Aspire Biopharma Holdings, Inc. company facts
Aspire Biopharma Holdings, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 738920107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
ASBP
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Friedman Lance | 4.5% | -42% | $1,037,706 | -$782,315 | 2,207,886 | -43% | Lance Friedman | 06 May 2025 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 5.2% | $182,200 | 273,000 | Highbridge Capital Management, LLC | 31 Mar 2026 | |||
| Harraden Circle Investments, LLC | 0.31% | $70,500 | 150,000 | Harraden Circle Investments, LLC | 31 Mar 2025 |
As of 31 Mar 2026, 2 institutional investors reported holding 25,348 shares of Aspire Biopharma Holdings, Inc. - Common Stock, par value $0.0001 per share (ASBP). This represents 0.48% of the company’s total 5,250,000 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Latest
Q1 2026
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 25,348 | $8,453 | -$841,693 | $0.67 | 2 |
| 2025 Q4 | 6,823,464 | $899,822 | +$486,842 | $0.13 | 30 |
| 2025 Q3 | 3,123,043 | $645,607 | +$222,104 | $0.21 | 25 |
| 2025 Q2 | 2,044,304 | $544,743 | -$131,309 | $0.27 | 16 |
| 2025 Q1 | 1,435,984 | $875,750 | +$875,750 | $0.58 | 15 |